| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |